CS logo
small CS logo
Shizuoka Cancer Center; Thoracic Oncology

Shizuoka, Japan
長泉町のがん治療センター

About Shizuoka Cancer Center; Thoracic Oncology


静岡県立静岡がんセンターは、静岡県が運営する医療機関。静岡県立静岡がんセンター事業の設置等に関する条例に基づき設置された県立の病院である。開設時より地方公営企業法を全部適用しており、2009年の地方独立行政法人静岡県立病院機構の設立時には同機構に移行していない。2013年4月1日付けで特定機能病院として承認された。
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Shizuoka Cancer Center; Thoracic Oncology


During the past decade, Shizuoka Cancer Center; Thoracic Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Shizuoka Cancer Center; Thoracic Oncology


According to Clinical.Site data, the most researched conditions in "Shizuoka Cancer Center; Thoracic Oncology" are "Non-Squamous Non-Small Cell Lung Cancer" (2 trials), "Small Cell Lung Carcinoma" (1 trials) and "Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Shizuoka Cancer Center; Thoracic Oncology" in a lesser frequency.

Clinical Trials Intervention Types at Shizuoka Cancer Center; Thoracic Oncology


Most popular intervention types in "Shizuoka Cancer Center; Thoracic Oncology" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Docetaxel" (2 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Shizuoka Cancer Center; Thoracic Oncology


The vast majority of trials in "Shizuoka Cancer Center; Thoracic Oncology" are 4 trials for "All" genders.

Clinical Trials Status at Shizuoka Cancer Center; Thoracic Oncology


Currently, there are NaN active trials in "Shizuoka Cancer Center; Thoracic Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Shizuoka Cancer Center; Thoracic Oncology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Shizuoka Cancer Center; Thoracic Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".